ChromaCode: Mark McDonough, Carol Gallagher, Michele Park
ChromaCode has appointed Mark McDonough as chair of its board of directors, effective Jan. 1, following the retirement of former chair, Carol Gallagher. The firm has also appointed Michele Park to the board.
Gallagher was a member of the board since 2015, while McDonough has served as CEO since January 2023 and was previously CEO of molecular diagnostics development firms CombiMatrix and Pierian.
Park is a partner at New Enterprise Associates. She previously served as partner at Clarus Ventures and as an investment analyst at Credit Suisse and Piper Jaffray. Park holds a bachelors degree in molecular biology from Princeton University and a PhD in molecular biology from Weill Cornell Graduate School of Medical Sciences.